报价延迟最少15分钟:2026/10/26 00:55 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.03 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-14.29/-2.17
|
|
企业价值
3.29M
|
| 资产负债 |
|
每股账面净值
11.92
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Eocene Ltd is a GI-focused medtech and biopharmaceutical company focused on advancing solutions across gastrointestinal disease management, GI oncology and related therapeutic areas. Its wholly owned subsidiary develops medical devices forpostoperative colorectal care, including CG-100, an intraluminal bypass device intended to protect colorectal anastomoses and reduce the need for diverting stomas. The company's therapeutic portfolio includes Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule being evaluated in liver disease and oncology indications, including gastrointestinal cancers. |
